Filing Details

Accession Number:
0000904454-13-000770
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-02 17:00:36
Reporting Period:
2013-07-01
Filing Date:
2013-07-02
Accepted Time:
2013-07-02 17:00:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372932 Dp Vii Associates Lp C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-01 30,462 $0.00 30,462 No 4 C Direct
Common Stock Acquisiton 2013-07-01 4,791 $14.00 35,253 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2013-07-01 30,462 $0.00 30,462 $0.00
Series A Preferred Stock Warrant to Purchase Series A Preferred Stock Disposition 2013-07-01 8,346 $0.00 8,346 $1.00
Common Stock Warrant to Purchase Common Stock Acquisiton 2013-07-01 1,193 $0.00 1,193 $6.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 J Direct
1,193 2018-02-12 No 4 J Direct
Footnotes
  1. All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
  2. Upon the closing of the IPO the Warrants to purchase Series A Preferred Stock automatically converted on a 6.986-for-1 basis into Warrants to purchase Common Stock, and the exercise price automatically adjusted to $6.99 per share, pursuant to the terms of such Warrants. This transaction is reported on Form 4 solely for the purpose of reflecting such changes.
  3. The Warrant is immediately exercisable.